SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-116598
Filing Date
2016-08-04
Accepted
2016-08-04 16:05:20
Documents
10
Period of Report
2016-08-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v445986_6k.htm 6-K 8636
2 NOTICE OF SPECIAL MEETING OF SHAREHOLDERS v445986_ex99-1.htm EX-99.1 1732692
3 GRAPHIC tex99-1_logo1.jpg GRAPHIC 31223
4 GRAPHIC tex99-1_stamp1.jpg GRAPHIC 33798
5 GRAPHIC tex99-1_stamp2.jpg GRAPHIC 23446
6 GRAPHIC tex99-1_sig1.jpg GRAPHIC 26578
7 GRAPHIC tex99-1_logo2.jpg GRAPHIC 7420
8 GRAPHIC tex99-1_logo3.jpg GRAPHIC 3178
9 GRAPHIC tex99-1_sig2.jpg GRAPHIC 7253
10 GRAPHIC tex99-1_chart.jpg GRAPHIC 49138
  Complete submission text file 0001144204-16-116598.txt   1994171
Mailing Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7
Business Address 101 COLLEGE STREET SUITE 220 TORONTO A6 M5G 1L7 416-260-7770
Transition Therapeutics Inc. (Filer) CIK: 0001399250 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-33514 | Film No.: 161807376
SIC: 2833 Medicinal Chemicals & Botanical Products